Tizanidine Tablet
Product Images NDC 68788-7781

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 68788-7781). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine Hydrochloride Tablet 4mg (Container1)

FDA Label Image

Fig1 (Fig1)

FDA Label Image

Fig2 (Fig2)

FDA Label Image

Fig3 (Fig3)

The text describes the improvement in Ashworth Score for a medication called zanidine, with a mean dose of 28.6 mg. It also mentions different study weeks, specifically ending at the third week and at the end of maintenance endpoint at the seventh week, using last observation garred forward method.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.